Interestingly, decreased REDD1 expression, a stress response gene which is associated with peroxisome proliferator activated receptor γ (PPARγ)/CD36 activation, predicts poor outcomes selectively in KRAS mutant but not KRAS wild-type human lung and pancreatic adenocarcinomas [7]. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.